Brian J. Lavey
28Patents
8h-index
73Co-inventors
74Inventor score
Filing activity: Nov 18, 1998 → Oct 3, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8178553B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 45 | Active |
| US8569336B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 43 | Active |
| US7504424B2 | Compounds for the treatment of inflammatory disorders | Emerging Cross-Sectional Technologies | 18 | Expired |
| US7488745B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 17 | Active |
| US7482370B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 12 | Expired |
| US7067539B2 | Cannabinoid receptor ligands | Chemistry; Metallurgy | 12 | Expired |
| US7524842B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 12 | Active |
| US7507767B2 | Cannabinoid receptor ligands | Chemistry; Metallurgy | 8 | Expired |
| US7071213B2 | Cannabinoid receptor ligands | Chemistry; Metallurgy | 8 | Expired |
| US6063926A | Substituted oximes as neurokinin antagonists | Chemistry; Metallurgy | 7 | Expired |
| US7687527B2 | Compounds for the treatment of inflammatory disorders | Emerging Cross-Sectional Technologies | 6 | Active |
| US6838466B2 | Compounds for the treatment of inflammatory disorders | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7879890B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 5 | Active |
| US7772263B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 5 | Active |
| US7683085B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 5 | Active |
| US7718702B2 | Cannabinoid receptor ligands | Chemistry; Metallurgy | 5 | Expired |
| US9221809B2 | Aminopyrimidinones as interleukin receptor-associated kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US9598440B2 | Inhibitors of IRAK4 activity | Chemistry; Metallurgy | 4 | Active |
| US7652020B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 3 | Expired |
| US8361959B2 | Spiro-imidazolone derivatives as glucagon receptor antagonists | Chemistry; Metallurgy | 2 | Active |
| US8541572B2 | Compounds for the treatment of inflammatory disorders | Human Necessities | 2 | Active |
| US7683088B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 1 | Active |
| US9254292B2 | Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases | Emerging Cross-Sectional Technologies | 1 | Active |
| US8450355B2 | Compounds for the treatment of inflammatory diseases | Chemistry; Metallurgy | 0 | Active |
| US7645774B2 | Cannabinoid receptor ligands | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.